Atea Pharmaceuticals

Pharmaceuticals

Stránky společnosti

Ticker

AVIR.NASDAQ

Trh

Rok založení

2014

Uzávěrka

11/10/2020

Datum IPO

10/29/2020

Cena umístění

$24

Ziskovost

19.71%

O společnosti

Total Funding

$283.4M

Atea Pharmaceuticals is a biopharmaceutical company engaged in the discovery and development of next-generation therapeutics for severe human viral infections. It caters to the healthcare industry and engages in the discovery and development of antiviral therapeutics that enable patients to have treatment for infections caused by RNA and DNA viruses.

Atea Pharmaceuticals was established in 2014 and is headquartered in Boston, Massachusetts.

Number of employees

11-50

Headquarters

Boston, Massachusetts, United States